TITLE

Essential medicines are hard to find in many poor countries

PUB. DATE
January 2004
SOURCE
Report on the Global HIV/AIDS Epidemic: UNAIDS - 2004;1/1/2004, p113
SOURCE TYPE
Book
DOC. TYPE
Article
ABSTRACT
The article reports that the large number of HIV-positive people in low- and middle- income countries lacks access even to relatively simple medications. Moreover, some countries with high burdens of AIDS have poor and unequal access to important drugs for any condition. In the poorest parts of Africa and Asia, more than 50 percent of the population do not have access to even the most basic essential medicines.
ACCESSION #
24749030

 

Related Articles

  • HIV's emerging gender gap. Aschwanden, Christie; Chen, Ingfei // Health (Time Inc. Health);Oct98, Vol. 12 Issue 7, p14 

    Looks at why men infected with the Acquired Immune Deficiency Syndrome (AIDS) virus are benefiting more from potent drugs than women who have tested positive for the human immunodeficiency virus (HIV), according to researchers from Johns Hopkins University. Contention that doctors are starting...

  • HIV/AIDS therapeutic strategies: A progress report. Fontaine, Colette; Dancer, Tina // Drug Topics;5/17/99, Vol. 143 Issue 9, p89 

    Focuses on several antiretroviral agents approved by the United States Food and Drug Administration for HIV and AIDS patients. Factors which contributes to patients' nonadherence to their medication; Goal of antiretroviral therapy; Information on the HIV life cycle and the antiretroviral...

  • Antiretroviral Medication Errors in a National Medication Error Database. Gray, Jennifer; Hicks, Rodney W.; Hutchings, Cristi // AIDS Patient Care & STDs;Dec2005, Vol. 19 Issue 12, p803 

    Antiretroviral medications have reduced the morbidity and mortality associated with HIV. In contrast to these benefits, medication errors involving antiretrovirals represent opportunities for causing harm. We analyzed 400 medication errors that involved at least one single or combined HIV...

  • Teaming up to provide HIV drugs to patients.  // AIDS Alert;Jul2010, Vol. 25 Issue 7, p82 

    The article focuses on the collaboration between the Heinz Family Philanthropies, Welvista and Abbott Laboratories Inc. to provide a solution for the treatment of HIV patients. It discusses the one-year program initiated by the three organizations which will help the patients who are on the AIDS...

  • Pharmaceutical Care of HIV/AIDS Patients in a Resource-poor Setting. Anafi, S. B.; Kwanashie, H. O.; Muktar, H. M. // Journal of Pharmaceutical Sciences & Research;2011, Vol. 3 Issue 9, p1466 

    Provision of pharmaceutical care to patients suffering from HIV/AIDS pose special challenges due to the complexity of the disease state, these challenges are greater in resource-poor countries such as Nigeria. Against this background, the aim of this study is to identify the pharmaceutical care...

  • Illustrations and implications of current models of HIV health service provision in rural areas. Mainous III, Arch G.; Noble, Robert C. // AIDS Patient Care & STDs;Feb1997, Vol. 11 Issue 1, p25 

    Discusses the implications of HIV/AIDS health-care delivery models in the rural areas in the United States. HIV epidemic in the rural areas; Evidence of patients splitting health care into HIV care; Case histories of models of HIV-related health care.

  • The first decade of antiretroviral therapy in Africa.  // Globalization & Health;2011, Vol. 7 Issue 1, p33 

    In this article the authors discuss the aspects of antiretroviral therapy (ART) programs in Africa over the decade of 2001. They state that the efforts of health providers, people living with HIV/AIDS, activists, and academics, have ensured access to ART in resource-limited settings of the...

  • Density of Healthcare Providers and Patient Outcomes: Evidence from a Nationally Representative Multi-Site HIV Treatment Program in Uganda. Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Zhang, Wendy; Hagopian, Amy; Ford, Nathan; Mills, Edward J. // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Objective: We examined the association between density of healthcare providers and patient outcomes using a large nationally representative cohort of patients receiving combination antiretroviral therapy (cART) in Uganda. Design: We obtained data from The AIDS Support Organization (TASO) in...

  • Indirect costs in ambulatory patients with HIV/AIDS in Spain: a pilot study. Oliva, Juan; Roa, César; del Llano, Juan; Roa, César // PharmacoEconomics;2003, Vol. 21 Issue 15, p1113 

    Objective: To estimate indirect costs in Spanish ambulatory patients with HIV/AIDS and to identify changes in employment status and their current QOL.Method: Information was obtained through 32 interviews/enquiries carried out with ambulatory patients receiving medical...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics